Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model.
about
Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Tumor-targeted SN38 inhibits g ...... as/p53 transgenic mouse model.
@ast
Tumor-targeted SN38 inhibits g ...... as/p53 transgenic mouse model.
@en
type
label
Tumor-targeted SN38 inhibits g ...... as/p53 transgenic mouse model.
@ast
Tumor-targeted SN38 inhibits g ...... as/p53 transgenic mouse model.
@en
prefLabel
Tumor-targeted SN38 inhibits g ...... as/p53 transgenic mouse model.
@ast
Tumor-targeted SN38 inhibits g ...... as/p53 transgenic mouse model.
@en
P2093
P2860
P1433
P1476
Tumor-targeted SN38 inhibits g ...... as/p53 transgenic mouse model.
@en
P2093
Anna S Nikonova
Anna V Gaponova
Erica A Golemis
Leora Haber
Meghan C Kopp
P2860
P304
P356
10.1371/JOURNAL.PONE.0176747
P407
P577
2017-04-28T00:00:00Z